ContributorsPublishersAdvertisers

NK Cell Destruction May Boost IL-15 Efficacy in Refractory Cancers

targetedonc.com
 2021-10-05

Cover picture for the articleIn an interview with Targeted Oncology™: Jeffrey Miller, MD, discussed the use of NK cell destruction to boost IL-15 efficacy in refractory tumors. IL-15, which is a homeostatic factor stimulating natural killer (NK) cells and T cells, has shown little anti-tumor activity as a monotherapy in patients with refractory cancers. Delivering...

www.targetedonc.com

Comments / 0

Comments / 0